<scp>Chronic myeloid leukaemia</scp> patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype-Reference-Cited by-同舟云学术

Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype

Published:2022-07-08 Issue:6 Volume:198 Page:1011-1015
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Harrington Patrick¹²^ORCID,Dillon Richard¹³,Radia Deepti¹^ORCID,McLornan Donal¹²^ORCID,Woodley Claire¹,Asirvatham Susan¹,Raj Kavita¹,Curto‐Garcia Natalia¹^ORCID,Saunders Jamie¹,Kordasti Shahram¹²,Harrison Claire¹²^ORCID,de Lavallade Hugues¹²

Affiliation:

1. Department of Clinical Haematology, Guy's & St Thomas' NHS Foundation Trust London UK

2. School of Cancer and Pharmaceutical Science, King's College London London UK

3. Department of Medicine and Molecular Genetics, King's College London London UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18302

Reference24 articles.

1. What are the considerations for tyrosine kinase inhibitor discontinuation in chronic-phase chronic myeloid leukemia?